首页> 美国卫生研究院文献>Proteome Science >Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment
【2h】

Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment

机译:麦考酚酸治疗后人类胚胎肾细胞系(HEK-293)的差异蛋白质组分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMycophenolic acid (MPA) is widely used as a post transplantation medicine to prevent acute organ rejection. In the present study we used proteomics approach to identify proteome alterations in human embryonic kidney cells (HEK-293) after treatment with therapeutic dose of MPA. Following 72 hours MPA treatment, total protein lysates were prepared, resolved by two dimensional gel electrophoresis and differentially expressed proteins were identified by QTOF-MS/MS analysis. Expressional regulations of selected proteins were further validated by real time PCR and Western blotting.
机译:背景霉酚酸(MPA)被广泛用作移植后的药物,以防止急性器官排斥。在本研究中,我们使用蛋白质组学方法来确定在用治疗剂量的MPA治疗后人胚胎肾细胞(HEK-293)中的蛋白质组变化。 MPA处理72小时后,制备了总蛋白裂解物,通过二维凝胶电泳进行了分离,并通过QTOF-MS / MS分析鉴定了差异表达的蛋白。通过实时PCR和蛋白质印迹进一步验证了所选蛋白质的表达规律。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号